Interruption of a drug regimen before anesthesia.
D000758:Anesthesia; D000890:Anti-Infective Agents / Q000009:adverse effects; D000925:Anticoagulants / Q000009:adverse effects; D000927:Anticonvulsants / Q000009:adverse effects; D000928:Antidepressive Agents / Q000009:adverse effects; D000959:Antihypertensive Agents / Q000009:adverse effects; D002301:Cardiac Glycosides / Q000009:adverse effects; D004295:Dihydroxyphenylalanine / Q000009:adverse effects; D004232:Diuretics / Q000009:adverse effects; D004347:Drug Interactions; D064420:Drug-Related Side Effects and Adverse Reactions; D004456:Echothiophate Iodide / Q000009:adverse effects; D006801:Humans; D007328:Insulin / Q000009:adverse effects; D008012:Lidocaine / Q000009:adverse effects; D008996:Monoamine Oxidase Inhibitors / Q000009:adverse effects; D009388:Neostigmine / Q000009:adverse effects; D010640:Phenothiazines / Q000009:adverse effects; D011342:Procainamide / Q000009:adverse effects; D011433:Propranolol / Q000009:adverse effects; D011802:Quinidine / Q000009:adverse effects; D014156:Transcortin / Q000009:adverse effects
D000890:Anti-Infective Agents; D000925:Anticoagulants; D000927:Anticonvulsants; D000928:Antidepressive Agents; D000959:Antihypertensive Agents; D002301:Cardiac Glycosides; D004232:Diuretics; D007328:Insulin; D008996:Monoamine Oxidase Inhibitors; D010640:Phenothiazines; D009388:Neostigmine; D004295:Dihydroxyphenylalanine; D014156:Transcortin; D008012:Lidocaine; D011433:Propranolol; D004456:Echothiophate Iodide; D011802:Quinidine; D011342:Procainamide